Related Experiment Video
Updated: Jan 5, 2026

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
Published on: March 31, 2023
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
Jung-A Choi1, Hyunja Kwon2, Hanbyoul Cho3
1Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea. jachoi@yuhs.ac.
Abstract:
Aldehyde dehydrogenase 1 family member A2 (ALDH1A2) is a rate-limiting enzyme involved in cellular retinoic acid synthesis. However, its functional role in ovarian cancer remains elusive. Here, we found that ALDH1A2 was the most prominently downregulated gene among ALDH family members in ovarian cancer cells, according to complementary DNA microarray data. Low ALDH1A2 expression was associated with unfavorable prognosis and shorter disease-free and overall survival for ovarian cancer patients. Notably, hypermethylation of ALDH1A2 was significantly higher in ovarian cancer cell lines when compared to that in immortalized human ovarian surface epithelial cell lines. ALDH1A2 expression was restored in various ovarian cancer cell lines after treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine. Furthermore, silencing DNA methyltransferase 1 (DNMT1) or 3B (DNMT3B) restored ALDH1A2 expression in ovarian cancer cell lines. Functional studies revealed that forced ALDH1A2 expression significantly impaired the proliferation of ovarian cancer cells and their invasive activity. To the best of our knowledge, this is the first study to show that ALDH1A2 expression is regulated by the epigenetic regulation of DNMTs, and subsequently that it might act as a tumor suppressor in ovarian cancer, further suggesting that enhancing ALDH1A2-linked signaling might provide new opportunities for therapeutic intervention in ovarian cancer.
Insights
Aldehyde dehydrogenase 1 family member A2 (ALDH1A2) is downregulated in ovarian cancer, linked to poor prognosis. Its expression is epigenetically silenced by DNA methyltransferases, and restoring ALDH1A2 inhibits cancer cell growth.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aldehyde dehydrogenase 1 family member A2 (ALDH1A2) is crucial for retinoic acid synthesis.
- The specific function of ALDH1A2 in ovarian cancer pathogenesis is not well understood.
- ALDH1A2 is among the most downregulated genes in ovarian cancer cells.
Purpose of the Study:
- To investigate the role of ALDH1A2 in ovarian cancer.
- To explore the epigenetic regulation of ALDH1A2 in ovarian cancer.
- To determine the impact of ALDH1A2 expression on ovarian cancer progression.
Main Methods:
- Complementary DNA microarray analysis to assess ALDH gene expression.
- Analysis of ALDH1A2 expression in relation to patient survival data.
- DNA methylation analysis and treatment with 5-aza-2'-deoxycytidine (DNA methylation inhibitor).
- Silencing of DNA methyltransferase 1 (DNMT1) and DNMT3B.
- Functional studies involving forced ALDH1A2 expression.
Main Results:
- ALDH1A2 was significantly downregulated in ovarian cancer cells compared to normal cells.
- Low ALDH1A2 expression correlated with unfavorable prognosis and reduced survival.
- Hypermethylation of ALDH1A2 was prevalent in ovarian cancer, and its expression could be restored by demethylation agents.
- Silencing DNMT1 or DNMT3B also restored ALDH1A2 expression.
- Forced ALDH1A2 expression suppressed ovarian cancer cell proliferation and invasion.
Conclusions:
- ALDH1A2 functions as a tumor suppressor in ovarian cancer.
- ALDH1A2 expression is epigenetically regulated by DNA methyltransferases.
- Restoring ALDH1A2 expression or its signaling pathways may offer novel therapeutic strategies for ovarian cancer.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs